A recent study from Cronin and Grealy (Neuroscience, 2017) investigates several existing drugs, like Isradipine (used for high blood pressure), Minocycline (antibiotic), and Rasagiline (normally used in conjuction with PD
drug Levodopa).
Although
the drug levodopa can relieve some symptoms, there is no cure — intensifying the pressure to find an animal model that can help clarify the pathological processes underlying human PD and find new medications to treat the pathology and / or relieve symptoms.
«But scientists are studying whether the Parkinson's
drug levodopa, which can ease movement symptoms, can also influence brain functions such as memory, quick thinking and learning.»
Since the 1960s, the gold - standard treatment for the disease has been
the drug levodopa, also known as L - dopa, a dopamine precursor that can cross the blood - brain barrier.
Not exact matches
Analyses were controlled for age, sex, education, exposure to study
drug, and prescribed dose of
levodopa.
Several studies have suggested
levodopa, a
drug for Parkinson's, may be implicated in malignant melanoma, but others have found an association between the two diseases regardless of
levodopa treatment, they add.
Objective: We performed a meta - analysis of zonisamide treatment in PD patients who received antiparkinson
drugs such as
levodopa.
This is also why
levodopa — the chemical building block of dopamine — is the go - to
drug for PD: giving the surviving dopamine - producing neurons more building blocks allows them to eke out more dopamine, going a long way toward correcting the subset of PD symptoms that are caused by loss of dopamine - producing cells (particularly in the early stages of the disease).
And for decades patients have taken a
drug called
Levodopa to boost the brain's dopamine levels.
Because most NMS are not driven primarily by loss of dopamine signaling,
levodopa and related dopamine - boosting
drugs are completely ineffective in controlling most of them; in fact, using the
drug can sometimes make some NMS worse.